A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)
Clinical trial NCT02004886 · COMPLETED
Trial details
- NCT number
- NCT02004886
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-11
- Primary completion
- 2007-02-07
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.